Cargando…
Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
The World Health Organization (WHO) recently added snakebite envenoming to the priority list of Neglected Tropical Diseases (NTD). It is thought that ~75% of mortality following snakebite occurs outside the hospital setting, making the temporal gap between a bite and antivenom administration a major...
Autores principales: | Bulfone, Tommaso C., Samuel, Stephen P., Bickler, Philip E., Lewin, Matthew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091453/ https://www.ncbi.nlm.nih.gov/pubmed/30154870 http://dx.doi.org/10.1155/2018/4320175 |
Ejemplares similares
-
Snakebite: An Exploratory Cost-Effectiveness Analysis of Adjunct Treatment Strategies
por: Herzel, Benjamin J., et al.
Publicado: (2018) -
Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes
por: Lewin, Matthew R., et al.
Publicado: (2022) -
Neuromuscular Weakness and Paralysis Produced by Snakebite Envenoming: Mechanisms and Proposed Standards for Clinical Assessment
por: Bickler, Philip E., et al.
Publicado: (2023) -
Delayed LY333013 (Oral) and LY315920 (Intravenous) Reverse Severe Neurotoxicity and Rescue Juvenile Pigs from Lethal Doses of Micrurus fulvius (Eastern Coral Snake) Venom
por: Lewin, Matthew R., et al.
Publicado: (2018) -
Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation
por: Lewin, Matthew, et al.
Publicado: (2016)